Vita 34 Ag Stock Analysis
| VTIAF Stock | USD 6.38 0.00 0.00% |
VITA 34 AG holds a debt-to-equity ratio of 0.841. VITA 34's financial risk is the risk to VITA 34 stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
VITA 34's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. VITA 34's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps VITA Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect VITA 34's stakeholders.
For many companies, including VITA 34, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for VITA 34 AG, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, VITA 34's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that VITA 34's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which VITA 34 is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of VITA 34 to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, VITA 34 is said to be less leveraged. If creditors hold a majority of VITA 34's assets, the Company is said to be highly leveraged.
VITA 34 AG is fairly valued with Real Value of 6.53 and Hype Value of 6.38. The main objective of VITA 34 pink sheet analysis is to determine its intrinsic value, which is an estimate of what VITA 34 AG is worth, separate from its market price. There are two main types of VITA 34's stock analysis: fundamental analysis and technical analysis.
The VITA 34 pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and VITA 34's ongoing operational relationships across important fundamental and technical indicators.
VITA |
VITA Pink Sheet Analysis Notes
About 68.0% of the company outstanding shares are owned by insiders. The book value of VITA 34 was at this time reported as 2.25. The company had not issued any dividends in recent years. VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany. Vita 34 operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 775 people.The quote for VITA 34 AG is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Jakub Baran at 49 341 48792 40 or visit https://www.vita34.de.VITA 34 AG Investment Alerts
| VITA 34 AG generated a negative expected return over the last 90 days | |
| VITA 34 AG has accumulated 10.93 M in total debt with debt to equity ratio (D/E) of 0.84, which is about average as compared to similar companies. VITA 34 AG has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist VITA 34 until it has trouble settling it off, either with new capital or with free cash flow. So, VITA 34's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VITA 34 AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VITA to invest in growth at high rates of return. When we think about VITA 34's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 28.42 M. Net Loss for the year was (3.67 M) with profit before overhead, payroll, taxes, and interest of 12.44 M. | |
| About 68.0% of VITA 34 outstanding shares are owned by insiders |
VITA Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 110.48 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VITA 34's market, we take the total number of its shares issued and multiply it by VITA 34's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.VITA Profitablity
The company has Profit Margin (PM) of (0.18) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.15) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.15.Technical Drivers
As of the 10th of February, VITA 34 has the Variance of 1.19, coefficient of variation of (812.40), and Risk Adjusted Performance of (0.1). Compared to fundamental indicators, the technical analysis model makes it possible for you to check available technical drivers of VITA 34 AG, as well as the relationship between them. Please validate VITA 34 AG standard deviation, as well as the relationship between the treynor ratio and kurtosis to decide if VITA 34 is priced fairly, providing market reflects its prevalent price of 6.38 per share. Given that VITA 34 AG has variance of 1.19, we advise you to double-check VITA 34 AG's current market performance to make sure the company can sustain itself next year.VITA 34 AG Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in VITA 34 price series with the more recent values given greater weights.
VITA 34 Predictive Daily Indicators
VITA 34 intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of VITA 34 pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
VITA 34 Forecast Models
VITA 34's time-series forecasting models are one of many VITA 34's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VITA 34's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.VITA 34 AG Debt to Cash Allocation
Many companies such as VITA 34, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
VITA 34 AG has accumulated 10.93 M in total debt with debt to equity ratio (D/E) of 0.84, which is about average as compared to similar companies. VITA 34 AG has a current ratio of 0.77, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist VITA 34 until it has trouble settling it off, either with new capital or with free cash flow. So, VITA 34's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VITA 34 AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VITA to invest in growth at high rates of return. When we think about VITA 34's use of debt, we should always consider it together with cash and equity.VITA 34 Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the VITA 34's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of VITA 34, which in turn will lower the firm's financial flexibility.About VITA Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how VITA 34 prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VITA shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as VITA 34. By using and applying VITA Pink Sheet analysis, traders can create a robust methodology for identifying VITA entry and exit points for their positions.
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany. Vita 34 operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange. It employs 775 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding VITA 34 to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Volatility Now
Portfolio VolatilityCheck portfolio volatility and analyze historical return density to properly model market risk |
| All Next | Launch Module |
Complementary Tools for VITA Pink Sheet analysis
When running VITA 34's price analysis, check to measure VITA 34's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VITA 34 is operating at the current time. Most of VITA 34's value examination focuses on studying past and present price action to predict the probability of VITA 34's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VITA 34's price. Additionally, you may evaluate how the addition of VITA 34 to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |